Abstract
Biological macromolecules such as proteins constitute an important class of products in the food, biotechnology, pharmaceutical, and cosmetics industries. The growing need to develop efficient and rapid protein purification methods is driving research and growth in this area. Advances and progress in the methods and techniques of protein purification have been such that one can reasonably expect that any protein of a given order of stability may be purified to currently acceptable standards of homogeneity. However, protein production cost remains extremely high, with downstream processing constituting a substantial proportion of the overall cost. Understanding of the methods and optimization of experimental conditions have become critical to the manufacturing industry in order to minimize production costs while satisfying all regulatory requirements. New purification protocols exploiting specific, effective, and robust methods and materials are expected to guide the future of the protein purification area.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Shendure J, Lieberman AE (2012) The expanding scope of DNA sequencing. Nat Biotechnol 30:1084–1094
Henry RJ, Edwards M, Waters DL et al (2012) Application of large-scale sequencing to marker discovery in plants. J Biosci 37:829–841
Vaudel M, Sickmann A, Martens L (2012) Current methods for global proteome identification. Expert Rev Proteomics 9:519–532
Marichal-Gallardo PA, Alvarez MM (2012) State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation. Biotechnol Prog 28:899–916
Kalyanpur M (2002) Downstream processing in the biotechnology industry. Mol Biotechnol 22:87–98
Kallberg K, Johansson HO, Bulow L (2012) Multimodal chromatography: an efficient tool in downstream processing of proteins. Biotechnol J 7:1485–1495
Cohn EJ, Edsall JT (1943) Proteins, amino acids and peptides as ions and dipolar ions. Reinhold Publishing, New York, NY
Lucy CA (2003) Evolution of ion-exchange: from Moses to the Manhattan Project to modern times. J Chromatogr A 1000:711–724
Starkenstein E (1910) Ferment action and the influence upon it of neutral salts. Biochem Z 24:210–218
Cuatrecasas P, Wilcheck M, Anfinsen CB (1968) Selective enzyme purification by affinity chromatography. Proc Natl Acad Sci U S A 61:636–643
Butler M, Meneses-Acosta A (2012) Recent advances in technology supporting biopharmaceutical production from mammalian cells. Appl Microbiol Biotechnol 96:885–894
Wilken LR, Nikolov ZL (2012) Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 30:419–433
Rosa PA, Azevedo AM, Sommerfeld S et al (2011) Aqueous two-phase extraction as a platform in the biomanufacturing industry: economical and environmental sustainability. Biotechnol Adv 29:559–567
Chon JH, Zarbis-Papastoitsis G (2011) Advances in the production and downstream processing of antibodies. Nat Biotechnol 28:458–463
Freitag R, Horváth C (1996) Chromatography in the downstream processing of biotechnological products. Adv Biochem Eng Biotechnol 53:17–59
Roque AC, Silva CS, Taipa MA (2007) Affinity-based methodologies and ligands for antibody purification: advances and perspectives. J Chromatogr A 1160:44–55
Labrou NE (2003) Design and selection of ligands for affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 790:67–78
Clonis YD (2006) Affinity chromatography matures as bioinformatic and combinatorial tools develop. J Chromatogr A 1101:1–24
Gottschalk U (2008) Bioseparation in antibody manufacturing: the good, the bad and the ugly. Biotechnol Prog 24:496–503
ISO 14644-1 (1999) Cleanrooms and associated controlled environments-part 1: classification of air cleanliness cleanroom standards
ISPE (2009) Baseline pharmaceutical engineering guides for new and renovated facilities. In: Biopharmaceuticals, vol 6. ISPE, Tampa, Fl, Glossary updated 06-23-2010
Rasmussen SK, Næsted H, Müller C et al (2012) Recombinant antibody mixtures: production strategies and cost considerations. Arch Biochem Biophys 526:139–145
Kelley B (2009) Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs 5:443–452
Dranitsaris G, Amir E, Dorward K (2011) Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations. Drugs 71:1527–1536
Davies HM (2010) Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8:845–861
Huang CJ, Lin H, Yang X (2012) Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J Ind Microbiol Biotechnol 39:383–399
Chen R (2012) Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol Adv 30:1102–1107
Young CL, Britton ZT, Robinson AS (2012) Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications. Biotechnol J 7:620–634
Protein Engineering Market [Products (monoclonal antibody, insulin analog, modified EPO), technology (sequential modification, glycosylation, pegylation), and applications (therapeutics, diagnostics, research)] – Global Forecast to 2017
Walsh G (2010) Biopharmaceutical benchmarks 2010. Nat Biotechnol 28:917–924
Global Biosimilars Market Forecast to 2015. http://www.reportlinker.com/p0795429-summary/Global-Biosimilars-Market-Forecast-to.html
Bird C (2011) Protein purification reagent market expands, role in biopharmaceutical, diagnostic, and basic biomedical research increases usage. Genetic engineering and biotechnology news, 31. http://www.genengnews.com/gen-articles/protein-purification-reagent-market-expands/3930/
Acknowledgements
This work was supported by the grants: AlgaeCom and AquaPhage (funded by the European Union, FP7), BioExplore (09ΣΥΝ-23-94, co-funded by the European Union—European Social Fund & National Resources), and THALES (MIS380236, co-funded by the European Union—European Social Fund & National Resources).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Labrou, N.E. (2014). Protein Purification: An Overview. In: Labrou, N. (eds) Protein Downstream Processing. Methods in Molecular Biology, vol 1129. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-977-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-62703-977-2_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-976-5
Online ISBN: 978-1-62703-977-2
eBook Packages: Springer Protocols